The Valley Desk

NCT00050076 · Interventional trial

Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.

Overall registry status Completed

Phase 2

Conditions Congestive Heart Failure

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov